Log In
Print
BCIQ
Print
Print this Print this
 

Respiratory Syncytial Virus (RSV) vaccine

  Manage Alerts
Collapse Summary General Information
Company Mymetics Corp.
DescriptionRSV vaccine comprised of reconstituted virosomes produced from RSV envelopes and containing the lipopeptide adjuvant P3CSK4
Molecular Target
Mechanism of ActionVaccine
Therapeutic ModalityPreventive vaccine
Latest Stage of DevelopmentPreclinical
Standard IndicationRespiratory syncytial virus (RSV)
Indication DetailsVaccinate against respiratory syncytial virus (RSV) infection
Regulatory Designation

Partner


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today